Rheumatology Doctors in Lively, VA Accepting Medicare
1 Rheumatology doctors found. Showing 1 - 1
 Dr. John Wesley Melton Iii, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 36 Lively Oaks Rd., Lively, VA 22507 Phone: 804-462-5155 Fax: 804-462-5922 |
News Archive
Delaware Physicians Care selected as one of the top 25 Medicaid Plans for the second consecutive year
For the second year in a row, Delaware Physicians Care has been selected as one of the top 25 Medicaid Plans out of hundreds in the nation by the National Committee for Quality Assurance (NCQA) and U.S. News & World Report magazine. The ranking is based on clinical quality, member satisfaction and NCQA accreditation scores.
Anti-LG3 associated with high rate of organ rejection during transplantation
A team led by Dr. Marie-Jos-e H-bert from the University of Montreal Hospital* Research Centre (CRCHUM) has discovered a new cause of organ rejection in some kidney transplant patients. Her team has identified a new class of antibodies - anti-LG3 - which when activated lead to severe rejection episodes associated with a high rate of organ loss.
Avita Medical introduces ReCell Spray-On Skin for chronic leg ulcers
Avita Medical Ltd., the regenerative medicine company, announced today that it has launched ReCell Spray-On Skin for the treatment of chronic leg ulcers, a market estimated at over US$1 billion.
Landrieu comments on President's signing of Patient Protection and Affordable Care Act
U.S. Senate Committee on Small Business and Entrepreneurship Chair Mary L. Landrieu, D-La., today commented on the President's signing of the Patient Protection and Affordable Care Act. The Act, passed by the U.S. House of Representatives Sunday evening, lowers costs and increases choices and stability for small businesses.
SENRI Trial: NK1 antagonists may prevent emesis in patients treated with oxaliplatin-based chemotherapy
The SENRI trial has opened the window to evaluate NK1 antagonists for emesis prevention in patients taking oxaliplatin chemotherapy, antiemetics expert and ESMO spokesperson Fausto Roila said, putting into perspective the results of a Japanese study presented today at the ESMO 17th World Congress on Gastrointestinal Cancer 2015 in Barcelona.
› Verified 9 days ago